Turning employee sentiment into hard operational data

Tern plc

Standard wellbeing programmes rarely solve the problems that matter. They tend to be broad, reactive, and detached from how a business actually runs. Managers see participation figures or survey responses and assume all is well.

That gap is now being addressed by tools built leadership decision-making. Instead of asking employees to rate how they feel, these tools extract meaning from how people actually speak, in comments, conversations and open-ended feedback.

Talking Medicines is one of the companies leading this shift. Its PeopleVoice platform translates employee language into operational insight. If a team is struggling with direction or motivation, it shows up early, before it hits output. It’s quantifiable risk data, broken down by cohort, trend and theme. And that data can be used to act precisely, not generally.

The strongest use cases are emerging in teams with high turnover or shifting targets. Instead of issuing another pulse survey or resilience webinar, leaders can see which roles are losing clarity, where communication is falling apart, or which functions are beginning to disengage.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern notes automotive momentum at Device Authority

Tern Plc notes that Device Authority, in which it holds a 25.3% stake, has announced further progress in the automotive sector, securing a new OEM customer and expanding an existing Tier 1 deployment.

Key management emerges as a delivery risk in automotive software

Key management is becoming a delivery-critical constraint in software-defined vehicles, influencing risk, compliance and programme scalability.

Pharma teams gain early insight into message effectiveness

Talking Medicines gives pharma teams early insight into which messages resonate with healthcare professionals.

Talking Medicines joins 2026 UK AI Index

Talking Medicines joins the UK AI Index 2026, confirming its growing role in data-driven healthcare strategy.

AI in Healthcare 2025

In 2025, AI began reshaping healthcare delivery and marketing with practical applications, signalling a maturing investment landscape.

Talking Medicines targets messaging risk in pharma brand strategy

Talking Medicines reduces messaging risk for pharma brands by measuring real-time HCP response.

Search

Search